ALZA Pharmaceuticals Overview

ALZA Corporation is the leading provider of drug delivery solutions with the world's broadest array of technology platforms, including oral, transdermal, implantable and liposomal technologies. ALZA partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for millions of patients worldwide. ALZA provides value to our...More»

ALZA Corporation is the leading provider of drug delivery solutions with the world's broadest array of technology platforms, including oral, transdermal, implantable and liposomal technologies. ALZA partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for millions of patients worldwide. ALZA provides value to our partners in all phases of product development, from initial concept, through manufacturing and commercialization. Many of our collaborations begin in the early phases of product development, using our pharmacologic discovery process to identify optimal delivery profiles. This process pushes the boundaries of drug delivery, and yields highly attractive options for partner companies to commercialize novel therapies. Through a merger completed on June 22, 2001, ALZA Corporation became a wholly owned subsidiary of Johnson & Johnson, the world's most comprehensive and broadly based manufacturer of heal«Less